Endo International plc Indenture Agreements

73 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Indenture for 6.125% Senior Secured Notes due 2029 among Endo Luxembourg Finance Company I S.à r.l., Endo U.S. Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
DE
2021
Supplemental Indenture to 6.000% Senior Notes Due 2025 Among Endo Designated Activity Company, Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2020
Supplemental Indenture to 6.000% Senior Notes Due 2023 Among Endo DAC, Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2020
Indenture for 6.000% Senior Notes due 2028 among Endo DAC, Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
DE
2020
Indenture for 9.500% Senior Secured Second Lien Notes due 2027 among Endo DAC, Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank
Indenture Agreements
Endo International plc
Pharmaceuticals
DE
2020
First Supplemental Indenture to 7.500% Senior Secured Notes Due 2027 – Par Pharmaceutical, Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
NY
2020
Supplemental Indenture to 5.75% Senior Notes Due 2022 among Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2019
Supplemental Indenture to 7.25% Senior Notes Due 2022 between Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2019
Indenture for 7.500% Senior Secured Notes due 2027 among Par Pharmaceutical, Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
NY
2019
Supplemental Indenture to 6.00% Senior Notes Due 2025 Among Endo Limited, Affiliates, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
NY
2016
Supplemental Indenture to 5.375% Senior Notes Due 2023 among Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
NY
2016
Supplemental Indenture to 7.25% Senior Notes Due 2022 among Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
NY
2016
Supplemental Indenture to 5.75% Senior Notes Due 2022 among Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2016
Supplemental Indenture for 6.000% Senior Notes Due 2023 among Par Pharmaceutical Subsidiaries and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture for 5.75% Senior Notes Due 2022 Among Endo Finance Entities, Subsidiaries, and Wells Fargo Bank as Trustee
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture to 6.00% Senior Notes Due 2025 Among Par Pharmaceutical Subsidiaries and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture to 5.375% Senior Notes Due 2023 among Par Pharmaceutical Companies, Inc., Subsidiaries, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture for 7.25% Senior Notes Due 2022 Among Endo Finance Entities, Par Pharmaceutical Subsidiaries, and Wells Fargo Bank
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Indenture for 6.000% Senior Notes Due 2023 among Endo Limited, Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
DE
2015
Supplemental Indenture to 7.00% Senior Notes Due 2020 among Par Pharmaceutical Subsidiaries, Endo Designated Activity Company, and Wells Fargo Bank
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture for 6.00% Senior Notes Due 2025 among Endo Entities and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture for 5.375% Senior Notes Due 2023 among Endo Finance Entities, Guarantors, and Wells Fargo Bank as Trustee
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture for 7.25% Senior Notes Due 2022 among Endo Entities and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture for 5.75% Senior Notes Due 2022 among Endo Entities and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture to 7.00% Senior Notes Due 2020 Among Endo Entities and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture to 7.00% Senior Notes Due 2019 among Endo Entities and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture for 6.00% Senior Notes Due 2025 Among Endo Subsidiaries and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture to 5.375% Senior Notes Due 2023—Endo Subsidiaries and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture for 5.75% Senior Notes Due 2022 among Endo Limited Subsidiaries and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture for 7.25% Senior Notes Due 2022 – Endo Limited and Subsidiaries, Wells Fargo Bank, N.A. as Trustee
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture to 7.00% Senior Notes Due 2020 Among Endo Subsidiaries and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture to 7.00% Senior Notes Due 2019 among Endo Subsidiaries and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture to 6.00% Senior Notes Due 2025 Among Endo Limited, Subsidiaries, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture to 5.375% Senior Notes Due 2023 Among Endo Entities and Wells Fargo Bank
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture for 5.75% Senior Notes Due 2022 among Endo Finance LLC, Endo Finco Inc., Aphrodite Women’s Health, LLC, Endo Ventures Cyprus Limited, and Wells Fargo...
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture to 7.25% Senior Notes Due 2022 Among Endo Entities and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture to 7.00% Senior Notes Due 2020 Among Endo Entities and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture to 7.00% Senior Notes Due 2019 Among Endo Entities and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture and Guarantee Agreement for 5.75% Senior Notes due 2022 among Endo Limited Subsidiaries and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture for 6.00% Senior Notes Due 2025 Among Endo Limited Subsidiaries and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015